[ad_1]
Ieq Capital LLC boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 287.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 45,298 shares of the pharmacy operator’s stock after purchasing an additional 33,593 shares during the quarter. Ieq Capital LLC’s holdings in Walgreens Boots Alliance were worth $423,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. State Street Corp increased its stake in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP purchased a new position in Walgreens Boots Alliance in the 3rd quarter worth about $24,226,000. Thompson Siegel & Walmsley LLC increased its stake in Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Stock Down 3.0 %
Shares of Walgreens Boots Alliance stock opened at $11.04 on Thursday. The firm has a market cap of $9.54 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.64. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The stock has a 50-day simple moving average of $10.44 and a 200-day simple moving average of $9.71.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the previous year, the company earned $0.66 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
WBA has been the topic of a number of analyst reports. Evercore ISI lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research note on Monday. Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $12.63.
View Our Latest Stock Report on WBA
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link